Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
Cardiovascular Research|September 1, 1976
Physiological disposition of verapamil in manM Schomerus, B Spiegelhalder, B Stieren, et al.
Clinical Pharmacokinetics|January 1, 1985
Carbamazepine metabolism in man. Induction and pharmacogenetic aspectsM Eichelbaum, T Tomson, G Tybring, et al.
British Journal of Clinical Pharmacology|November 1, 1986
Pharmacokinetics of midazolam in relation to polymorphic sparteine oxidationU Klotz, G Mikus, C Zekorn, et al.
Journal of Neurology|October 7, 1977
The bioavailability of phenytoinR Gugler, W Fröscher, M Eichelbaum, et al.
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1970
[Distribution pattern of chlorphentermine in rats, rabbits and swine]M Eichelbaum, J H Hengstmann, H J Dengler
Physical Review Letters|March 17, 2011
X-ray-assisted formation of gold nanoparticles in soda lime silicate glass: suppressed Ostwald ripeningD Tatchev, A Hoell, M Eichelbaum, et al.
Therapeutic Drug Monitoring|August 1, 1996
Stereoselectivity in drug metabolism and action: effects of enzyme inhibition and inductionH K Kroemer, M F Fromm, M Eichelbaum
Arzneimittel-Forschung|January 1, 1973
[A specific and sensitive method for the analysis of prenylamine and its derivatives in biological materials]M Eichelbaum, H J Hengstmann, H J Dengler
British Journal of Clinical Pharmacology|May 1, 1982
6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteineB K Park, M Eichelbaum, E E Ohnhaus
Clinical Pharmacology and Therapeutics|February 1, 1982
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entitiesM Eichelbaum, L Bertilsson, J Säwe, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
Cardiovascular Research|September 1, 1976
Physiological disposition of verapamil in manM Schomerus, B Spiegelhalder, B Stieren, et al.
Clinical Pharmacokinetics|January 1, 1985
Carbamazepine metabolism in man. Induction and pharmacogenetic aspectsM Eichelbaum, T Tomson, G Tybring, et al.
British Journal of Clinical Pharmacology|November 1, 1986
Pharmacokinetics of midazolam in relation to polymorphic sparteine oxidationU Klotz, G Mikus, C Zekorn, et al.
Journal of Neurology|October 7, 1977
The bioavailability of phenytoinR Gugler, W Fröscher, M Eichelbaum, et al.
Naunyn-Schmiedebergs Archiv Fur Pharmakologie|January 1, 1970
[Distribution pattern of chlorphentermine in rats, rabbits and swine]M Eichelbaum, J H Hengstmann, H J Dengler
Physical Review Letters|March 17, 2011
X-ray-assisted formation of gold nanoparticles in soda lime silicate glass: suppressed Ostwald ripeningD Tatchev, A Hoell, M Eichelbaum, et al.
Therapeutic Drug Monitoring|August 1, 1996
Stereoselectivity in drug metabolism and action: effects of enzyme inhibition and inductionH K Kroemer, M F Fromm, M Eichelbaum
Arzneimittel-Forschung|January 1, 1973
[A specific and sensitive method for the analysis of prenylamine and its derivatives in biological materials]M Eichelbaum, H J Hengstmann, H J Dengler
British Journal of Clinical Pharmacology|May 1, 1982
6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteineB K Park, M Eichelbaum, E E Ohnhaus
Clinical Pharmacology and Therapeutics|February 1, 1982
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entitiesM Eichelbaum, L Bertilsson, J Säwe, et al.
Pageof 27